Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation

A. J.J. Ijsselmuiden; P. W. Serruys; A. Scholte; F. Weber; C. A. Nienaber; Michael P. Savage; Francesco Burzotta

doi:10.1016/S1361-2611(03)00071-X

Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation

A. J.J. Ijsselmuiden, P. W. Serruys, A. Scholte, F. Weber, C. A. Nienaber, Michael P. Savage, Francesco Burzotta

Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Short survey › peer-review

Original language	English
Pages (from-to)	138-140
Number of pages	3
Journal	Evidence-based Cardiovascular Medicine
Volume	7
Issue number	3
DOIs	https://doi.org/10.1016/S1361-2611(03)00071-X
Publication status	Published - Sep 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1361-2611(03)00071-X

Cite this

@article{c5b47a7130754e34bc83570e33ff3863,

title = "Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation",

author = "Ijsselmuiden, \{A. J.J.\} and Serruys, \{P. W.\} and A. Scholte and F. Weber and Nienaber, \{C. A.\} and Savage, \{Michael P.\} and Francesco Burzotta",

year = "2003",

month = sep,

doi = "10.1016/S1361-2611(03)00071-X",

language = "English",

volume = "7",

pages = "138--140",

journal = "Evidence-based Cardiovascular Medicine",

issn = "1361-2611",

publisher = "Churchill Livingstone",

number = "3",

}

TY - JOUR

T1 - Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation

AU - Ijsselmuiden, A. J.J.

AU - Serruys, P. W.

AU - Scholte, A.

AU - Weber, F.

AU - Nienaber, C. A.

AU - Savage, Michael P.

AU - Burzotta, Francesco

PY - 2003/9

Y1 - 2003/9

UR - https://www.scopus.com/pages/publications/3042793893

U2 - 10.1016/S1361-2611(03)00071-X

DO - 10.1016/S1361-2611(03)00071-X

M3 - Short survey

AN - SCOPUS:3042793893

SN - 1361-2611

VL - 7

SP - 138

EP - 140

JO - Evidence-based Cardiovascular Medicine

JF - Evidence-based Cardiovascular Medicine

IS - 3

ER -

Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation

UN SDGs

Access to Document

Other files and links

Cite this